Omnicell is trading at $35.57, up 1.4% in pre-market; no clear Omnicell-specific catalyst was found for October 19. - The company’s third-quarter results are scheduled for October 29. - The S&P 500 and Nasdaq are higher, while the Dow is lower; the mixed snapshot does not establish a reason for Omnicell’s move. - The gain is below the alert’s 3% threshold, and the supplied price context includes no pre-market volume or activity data.